Xvivo Perfusion (Sweden) Analysis
| XVIVO Stock | SEK 480.00 7.50 1.59% |
Xvivo Perfusion AB is fairly valued with Real Value of 470.16 and Hype Value of 480.0. The main objective of Xvivo Perfusion stock analysis is to determine its intrinsic value, which is an estimate of what Xvivo Perfusion AB is worth, separate from its market price. There are two main types of Xvivo Perfusion's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Xvivo Perfusion's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Xvivo Perfusion's stock to identify patterns and trends that may indicate its future price movements.
The Xvivo Perfusion stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Xvivo Perfusion is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Xvivo Stock trading window is adjusted to Europe/Stockholm timezone.
Xvivo |
Xvivo Stock Analysis Notes
About 12.0% of the company outstanding shares are owned by insiders. The book value of Xvivo Perfusion was at this time reported as 47.94. The company has Price/Earnings (P/E) ratio of 662.55. Xvivo Perfusion AB had not issued any dividends in recent years. Xvivo Perfusion AB , a medical technology company, provides solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. Xvivo Perfusion AB was founded in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 45 people. For more information please call Magnus Nilsson at 46 3 17 88 21 50 or visit https://www.xvivoperfusion.com.Xvivo Perfusion AB Investment Alerts
| Xvivo Perfusion AB generated a negative expected return over the last 90 days | |
| Xvivo Perfusion AB has accumulated about 398.7 M in cash with (12.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.45. | |
| Roughly 12.0% of the company outstanding shares are owned by insiders |
Xvivo Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xvivo Perfusion's market, we take the total number of its shares issued and multiply it by Xvivo Perfusion's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Xvivo Profitablity
Xvivo Perfusion's profitability indicators refer to fundamental financial ratios that showcase Xvivo Perfusion's ability to generate income relative to its revenue or operating costs. If, let's say, Xvivo Perfusion is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Xvivo Perfusion's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Xvivo Perfusion's profitability requires more research than a typical breakdown of Xvivo Perfusion's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. Technical Drivers
As of the 1st of December, Xvivo Perfusion maintains the Mean Deviation of 1.63, market risk adjusted performance of (0.60), and Standard Deviation of 2.11. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xvivo Perfusion AB, as well as the relationship between them. Please check out Xvivo Perfusion AB variance and skewness to decide if Xvivo Perfusion AB is priced fairly, providing market reflects its latest price of 480.0 per share.Xvivo Perfusion AB Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Xvivo Perfusion middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Xvivo Perfusion AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Xvivo Perfusion Outstanding Bonds
Xvivo Perfusion issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Xvivo Perfusion AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Xvivo bonds can be classified according to their maturity, which is the date when Xvivo Perfusion AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Xvivo Perfusion Predictive Daily Indicators
Xvivo Perfusion intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Xvivo Perfusion stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Xvivo Perfusion Forecast Models
Xvivo Perfusion's time-series forecasting models are one of many Xvivo Perfusion's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Xvivo Perfusion's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Xvivo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Xvivo Perfusion prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Xvivo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Xvivo Perfusion. By using and applying Xvivo Stock analysis, traders can create a robust methodology for identifying Xvivo entry and exit points for their positions.
Xvivo Perfusion AB , a medical technology company, provides solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. Xvivo Perfusion AB was founded in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 45 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Xvivo Perfusion to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Additional Tools for Xvivo Stock Analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.